MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)

Lobbying client · District of Columbia · filed 2026 to 2026

Represents and protects the interests of midsized biopharmaceutical innovators.

$460,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (72567), not by name.

Firms hired 1

LMH STRATEGIC SOLUTIONS $460,000 3 filings

Reported by year 1 year

2026 $460,000 3 filings

Issues lobbied 2

Medicare/Medicaid 3
Pharmacy 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 3 total

Q2

LMH STRATEGIC SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $230,000 income · posted Jul 5, 2026

View → Q1

LMH STRATEGIC SOLUTIONS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $230,000 income · posted Apr 20, 2026

View → RR

LMH STRATEGIC SOLUTIONS

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 17, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.